Results 61 - 70 of 1450 : Previous 3 4 5 6 7 8 9 10 11 Next
A Dividend Raise 7 Years in the Making
Merck investors get a long-awaited pay increase.
Here's How Bristol-Myers Squibb Is Making You So Much, So Fast
Don't just count the cash, time it.
Byetta Breakup! Buying Opportunity?
We all saw this coming.
These stocks just rolled over. Can they come back?
Understanding how you got from A to B.
Biotech Pops, Drops, and Break-Ups
Highlighting the day's health-care stories critical to investors.
Amylin Pharmaceuticals Shares Plummeted: What You Need to Know
Is this meaningful? Or just another movement?
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
The divorce was presented today as an amicable ending to a long and fruitful partnership, but Amylin has been acting anything but amicably over the course of the year.
1 Reason the Street Should Love Eli Lilly's Earnings
Don't just count the cash, time it.
This Dividend King Could Lose Its Throne
A longtime dividend payer is in danger of having a long streak end.